MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis

被引:0
作者
Vladimir Vasku
Julie Bienertova-Vasku
Miroslav Necas
Anna Vasku
机构
[1] Masaryk University Brno,1st Department of Dermatology, St. Ann’s Faculty Hospital
[2] Masaryk University,Department of Pathophysiology, Faculty of Medicine
来源
Clinical and Experimental Medicine | 2009年 / 9卷
关键词
MTHFR; Polymorphism; Psoriasis; Folate; DNA methylation;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the study was to evaluate possible association of MTHFR C677T gene polymorphism (NM_005957) with psoriasis. Genotypes of MTHFR C677T gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. Case group (n = 410) included patients with psoriasis (plaque psoriasis diagnosed in 285 patients, other subtypes of psoriasis were observed in 125 patients). Control group (n = 244) consisted of healthy subjects without individual history of psoriasis, with similar age and gender characteristics. The MTHFR C677T polymorphism genotypes were determined by a polymerase chain reaction and a subsequent restriction analysis with HinfI. The genotypes of C(677)T methylenetetrahydrofolate reductase (MTHFR) gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. We proved a significant difference in genotype distribution (Pg = 0.03) and allelic frequency (Pa = 0.02) between psoriatic and control subjects (Table 3). The CC (the thermostabile) genotype was significantly more frequent in psoriatic patients compared to controls [OR = 1.55, 95% confidential interval (CI) = 1.12–2.15, P = 0.004814, Pcorr = 0.01]. But, a significant increase of T allele in MTHFR gene was observed in patients with positive family history of diabetes (Pa = 0.02) and in those with a frequent tonsillitis/tonsillectomy (Pa = 0.04). No difference was observed between patients with and without positive family history of psoriasis (Pa = 0.251). But, when psoriatic patients were described for FHDM, FH-Ps, and PH-T simultaneously, The highest incidence of CT + TT genotypes was calculated for psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy compared to patients without all these three phenotypes (odds ratio = 3.17, 95% CI 1.33–7.56, Pcorr = 0.04). In conclusion, MTHFR C677T polymorphism is marginally associated with psoriasis. The T allele (thermolabile) appears to be more frequent in psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy. This could reflect an inborn predisposition in complex regulation in one-carbon moieties transport in psoriatic patients and therefore, MTHFR genotype can be a part of genetic background of psoriasis.
引用
收藏
页码:327 / 331
页数:4
相关论文
共 50 条
  • [41] Methylenetetrahydrofolate Reductase (MTHFR) C677T and A1298C Gene Polymorphism as Risk Factors for Essential Hypertension
    Pratamawati, Tiar Masykuroh
    Alwi, Idrus
    Asmarinah
    INTERNATIONAL JOURNAL OF TECHNOLOGY, 2022, 13 (08) : 1622 - 1629
  • [42] Homozygous C677T Methylenetetrahydrofolate Reductase (MTHFR) Polymorphism as a Risk Factor for Endometriosis: A Retrospective Case-Control Study
    Delli Carpini, Giovanni
    Giannella, Luca
    Di Giuseppe, Jacopo
    Montik, Nina
    Montanari, Michele
    Fichera, Mariasole
    Crescenzi, Daniele
    Marzocchini, Carolina
    Meccariello, Maria Liberata
    Di Biase, Donato
    Vignini, Arianna
    Ciavattini, Andrea
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [43] Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk for Male Infertility in Asian Population
    Rai V.
    Kumar P.
    Indian Journal of Clinical Biochemistry, 2017, 32 (3) : 253 - 260
  • [44] The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women
    Sull, JW
    Jee, SH
    Yi, S
    Lee, JE
    Park, JS
    Kim, S
    Ohrr, H
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 557 - 563
  • [45] Methylenetetrahydrofolate reductase C677T polymorphism in patients with Henoch-Schonlein purpura
    Emre, Sevinc
    Sirin, Aydan
    Ergen, Arzu
    Bilge, Ilmay
    Sucu, Aysegul
    Yilmaz, Alev
    Isbir, Turgay
    PEDIATRICS INTERNATIONAL, 2011, 53 (03) : 358 - 362
  • [46] Predicting Hyperhomocysteinemia by Methylenetetrahydrofolate Reductase C677T Polymorphism in Chinese Patients With Hypertension
    Wang, Yu
    Xu, Xin
    Huo, Yong
    Liu, Dahai
    Cui, Yimin
    Liu, Zeyuan
    Zhao, Zhigang
    Xu, Xiping
    Liu, Lisheng
    Li, Xiaoying
    Jiang, Shanqun
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (07) : 661 - 666
  • [47] Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients
    Mrissa, Najiba Fekih
    Mrad, Meriem
    Klai, Sarra
    Zaouali, Jamel
    Sayeh, Aycha
    Mazigh, Chakib
    Nsiri, Brahim
    Machgoul, Salem
    Gritli, Nasreddine
    Mrissa, Ridha
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (09) : 1657 - 1660
  • [48] Association of congenital cardiac defects and the C677T methylenetetrahydrofolate reductase polymorphism
    Wintner, Sonja
    Hafner, Erich
    Stonek, Felix
    Stuempflen, Ingrid
    Metzenbauer, Martin
    Philipp, Karl
    PRENATAL DIAGNOSIS, 2007, 27 (08) : 704 - 708
  • [49] Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in Turkish postmenopausal women with osteoporosis
    Doganer, Fulya
    Soyocak, Ahu
    Cosan, Didem Turgut
    Ozgen, Merih
    Berkan, Funda
    Mutlu, Fezan Sahin
    Degirmenci, Irfan
    Gunes, Hasan Veysi
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2024,
  • [50] Roles of methylenetetrahydrofolate reductase C677T polymorphism in repeated pregnancy loss
    Wiwanitkit, V
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2005, 11 (03) : 343 - 345